Novo Nordisk A/S (NVO)

39.88 -7.54 (-15.89%) USD  |  NYSE  |  Feb 23, 13:33
More

Novo Nordisk Cash from Other Financing Activities (Quarterly)

Cash from Other Financing Activities (Quarterly) Chart

View Cash from Other Financing Activities (Quarterly) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Other Financing Activities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Other Financing Activities (Quarterly) Benchmarks

View Cash from Other Financing Activities (Quarterly) Benchmarks
Start Trial
Ascendis Pharma A/S Upgrade
Evaxion AS --
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. --
DBV Technologies SA --